Cyclacel Pharmaceuticals, Inc. (CYCC) Financials
CYCC Assets vs Liabilities
Date | Assets | Liabilities |
---|---|---|
2023-09-30 | 12.4 million | 8.1 million |
2023-06-30 | 16.4 million | 6.8 million |
2023-03-31 | 22.1 million | 7.4 million |
2022-12-31 | 27.5 million | 12.0 million |
CYCC Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
Date | Free Cash Flow | Stock based compensation |
---|---|---|
2023-09-30 | -4.0 million | 391000 |
2023-06-30 | -1.3 million | 359000 |
2023-03-31 | -6.9 million | 401000 |
2022-12-31 | -5.2 million | 387000 |
CYCC Net Income
No data available :(
CYCC Cash and Debt
Graph available only for supporters. Become a supporter to see it.
Date | Cash | Debt | Capital Lease |
---|---|---|---|
2023-09-30 | 5.9 million | - | 52000 |
2023-06-30 | 10.2 million | - | 66000 |
2023-03-31 | 11.4 million | - | 80000 |
2022-12-31 | 18.3 million | - | 106000 |
CYCC Shares Outstanding
CYCC Expenses
Graph available only for supporters. Become a supporter to see it.
Date | Capex | R&D | G&A | S&M |
---|---|---|---|---|
2023-09-30 | - | 5.2 million | 1.6 million | - |
2023-06-30 | - | 4.7 million | 1.6 million | - |
2023-03-31 | 6000 | 5.7 million | 1.6 million | - |
2022-12-31 | 2 | 6.7 million | 2.1 million | - |
CYCC Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
Date | Revenue | Cost of Revenue |
---|---|---|
2023-09-30 | 16000 | 7000 |
2023-06-30 | 373000 | 372627 |
2023-03-31 | - | 8000 |
2022-12-31 | - | 8000 |
CYCC
Price: $2
52 week price:
Earnings Per Share: -26.75 USD
P/E Ratio: -0.07
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Volume: 123100
Ebitda: -2.1 millionMarket Capitalization: 2.8 million